The Medical journal of Australia
-
Clinical Trial Controlled Clinical Trial
Is the Australian version of the Feingold diet safe?
Dietary intake data which were collected in the course of a trial on 16 children, who were diagnosed as being hyperactive, are examined. The nutritional adequacy of the children's diets before and during treatment with the Australian version of the Feingold elimination diet is calculated. ⋯ The nutritional quality, in terms of the level and balance of nutrients in the elimination test diet, was superior to that of the normal diet. With proper dietary counselling, the elimination test diet is safe for use in the treatment of children with hyperkinesis.
-
Clinical Trial Controlled Clinical Trial
Salicylate sensitivity in children reported to respond to salicylate exclusion.
Twelve children, aged six to 13 years, whose parents reported an improvement in behavioural problems with use of the Feingold (K-P) diet for an average period of 12 months, were challenge-tested with 40 mg of acetylsalicylic acid in a double-blind, cross-over trial with ascorbic acid as a placebo. The children were tested within three hours of ingestion of either the experimental or placebo tablet with a battery of psychological and neurological tests, and were rated by a parent on an enlarged Conners' Parent-Teacher Questionnaire for four days after the ingestion of the tablet. It was found that significance was reached in tests of general cognitive capacity, line walking and the "finger-to-nose" tests, as well as increased disturbance in sleep patterns in these children.
-
Editorial Comparative Study
Transmission of hepatitis B from mother to infant.
-
A patient developed a hypernephroma in his only fuctioning kidney. This was treated by nephrectomy, bench surgery which involved excision of the tumour and repair of the kidney, and autotransplantation. The patient remains well with good renal function, and no recurrent or metastatic disease.